Taka
US Dollar
Product Description
Originally created and approved for management of type 2 diabetes and obesity. Tirzepatide enhances insulin secretion, improves insulin sensitivity, and suppresses appetite, leading to significant reductions in blood glucose levels and body weight by simultaneously activating both GIP and GLP-1 receptors.
